Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $84.7 million.

  • Privia Health's Accounts Payables rose 2898.65% to $84.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.7 million, marking a year-over-year increase of 2898.65%. This contributed to the annual value of $82.0 million for FY2024, which is 4176.83% up from last year.
  • Latest data reveals that Privia Health reported Accounts Payables of $84.7 million as of Q3 2025, which was up 2898.65% from $74.3 million recorded in Q2 2025.
  • In the past 5 years, Privia Health's Accounts Payables registered a high of $84.7 million during Q3 2025, and its lowest value of $3.3 million during Q3 2021.
  • In the last 5 years, Privia Health's Accounts Payables had a median value of $50.7 million in 2024 and averaged $49.3 million.
  • As far as peak fluctuations go, Privia Health's Accounts Payables surged by 134681.57% in 2022, and later skyrocketed by 464.93% in 2023.
  • Quarter analysis of 5 years shows Privia Health's Accounts Payables stood at $46.0 million in 2021, then increased by 14.9% to $52.8 million in 2022, then grew by 9.45% to $57.8 million in 2023, then soared by 41.77% to $82.0 million in 2024, then grew by 3.27% to $84.7 million in 2025.
  • Its Accounts Payables stands at $84.7 million for Q3 2025, versus $74.3 million for Q2 2025 and $68.1 million for Q1 2025.